Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00303901 · ClinicalTrials.gov registry record · NA
Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery
A NA study, sponsored by Barbara Ann Karmanos Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00303901 is a NA study that has completed, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 40 participants.
The verdict
NCT00303901, a NA study, has completed, sponsored by Barbara Ann Karmanos Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
RATIONALE: Cryotherapy kills tumor cells by freezing them. This may be an effective treatment for primary lung cancer or lung metastases that cannot be removed by surgery. PURPOSE: This clinical trial is studying how well cryotherapy works in treating patients with primary lung cancer or lung metastases that cannot be removed by surgery.
Interventions
- PROCEDURE positron emission tomography
- PROCEDURE cryosurgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2005-11 |
| Est. Completion | 2011-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00303901
The ClinicalTrials.gov registry entry for NCT00303901 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Barbara Ann Karmanos Cancer Institute, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which positron emission tomography is the first listed.
NCT00303901 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00303901 about?
NCT00303901 is a clinical study titled "Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery". RATIONALE: Cryotherapy kills tumor cells by freezing them. This may be an effective treatment for primary lung cancer or lung metastases that cannot be removed by surgery. PURPOSE: This clinical trial is studying how well cryotherapy works in treating patients with primary lung cancer or lung metas...
What is the current status of trial NCT00303901?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2005-11. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00303901?
The interventions under investigation include: positron emission tomography (PROCEDURE), cryosurgery (PROCEDURE).
Who is sponsoring clinical trial NCT00303901?
This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.